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Abstract
Temporo-mandibular joint disc disorders are highly prevalent in adult populations. Autologous chondrocyte implantation is
a well-established method for the treatment of several chondral defects. However, very few studies have been carried out
using human fibrous chondrocytes from the temporo-mandibular joint (TMJ). One of the main drawbacks associated to
chondrocyte cell culture is the possibility that chondrocyte cells kept in culture tend to de-differentiate and to lose cell
viability under in in-vitro conditions. In this work, we have isolated human temporo-mandibular joint fibrochondrocytes
(TMJF) from human disc and we have used a highly-sensitive technique to determine cell viability, cell proliferation and
gene expression of nine consecutive cell passages to determine the most appropriate cell passage for use in tissue
engineering and future clinical use. Our results revealed that the most potentially viable and functional cell passages were
P5–P6, in which an adequate equilibrium between cell viability and the capability to synthesize all major extracellular matrix
components exists. The combined action of pro-apoptotic (TRAF5, PHLDA1) and anti-apoptotic genes (SON, HTT, FAIM2)
may explain the differential cell viability levels that we found in this study. These results suggest that TMJF should be used
at P5–P6 for cell therapy protocols.
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Introduction
The temporo-mandibular joint (TMJ) disc is a fibrocartilag-
inous tissue that lies between the mandibular condyle and the
temporal fossa-eminence. Several disorders may affect the TMJ
disc, including intra-articular positional and structural abnor-
malities with high prevalence in adult populations, especially
TMJ degenerative diseases, known as osteoarthrosis or osteoar-
thritis. Clinical management of the most prevalent TMJ disc
disorders is very challenging due to the low regeneration
capability of human cartilage, and emerging therapies based on
cultured human TMJF and tissue engineering represent a novel
treatment possibility [1,2].
The TMJ disc is mainly composed by fibrochondrocytes
(TMJF), which have features of both chondrocytes and
fibroblasts [3]. Human TMJF are known to have the capability
to synthetize different fibrillar extracellular matrix (ECM)
constituents, mainly collagen, and several non-fibrillar compo-
nents, and to proliferate faster than hyaline chondrocytes [4].
The distribution of TMJF into the disc appears to be
heterogeneous, and cells tend to show a round morphology
surrounded by pericellular matrix.
Several efforts are currently ongoing in the field of TMJ disc
tissue engineering using an immense variety of scaffolds and cell
sources [5,6,7]. Nevertheless, the scarce number of cells that can
be obtained from small TMJ disc tissue biopsies and the drop of
cell viability and cell differentiation levels caused by continuous
cell passaging in order to obtain large amounts of cells, are
significant limitations associated to TMJF culturing and TMJ disc
tissue engineering [8,9]. All these limitations can result in the
failure of cell therapy and tissue engineering strategies of the
human TMJ disc repair. For these reasons, a deep study of
sequential cell passages of cultured human TMJF might be a useful
tool for tissue engineers in order to select the most suitable cell
passage in terms of cell viability and differentiation from a clinical
standpoint. In fact, several previous studies previously demon-
strated that cell viability may vary among several cell passages and
that selection of the most adequate cell passage is very important
for cell therapy success [10,11].
In this study, we carried out a comprehensive analysis of cell
proliferation, cell viability and cell function on 9 consecutive cell
passages of human TMJF to determine which passage is the most
adequate for future clinical use.
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Materials and Methods
Isolation and Seeding of TMJF
TMJF were isolated from the retrodiscal area of human adult
TMJ discs. First, biopsies were obtained during arthroscopical
examination in patients with temporo-mandibular dysfunction
syndrome without involvement of the retrodiscal area. Samples
were kept at 4uC in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma-Aldrich) supplemented with antibiotics and
antimycotics (100 U/ml of penicillin G, 100 mg/ml of strepto-
mycin and 0.25 mg/ml of amphotericin B; Sigma-Aldrich) and
processed in the following 24 h. Then, an overnight enzymatic
digestion was performed by using 2 mg/ml collagenase type II
Clostridium hystoliticum (Gibco BRL Life Technologies Ref. 17100-
017, Karlsruhe, Germany). Isolated cells were cultured on tissue
culture flasks using a 3:1 mixture of DMEM and Ham’s F12
culture media supplemented with 10% fetal bovine serum (FBS),
1% antibiotics, 24 mg/ml adenine, 0.4 mg/ml hydrocortisone,
5 mg/ml insulin, 10 ng/ml epidermal growth factor, 1.3 ng/ml
triiodothyronine and 8 ng/ml of cholera toxin (all from Sigma-
Aldrich). Subconfluent cells were passaged with 0.05% trypsin-
EDTA (Sigma-Aldrich ref. T4299) and subcultured for nine
consecutive passages (P1 to P9). All patients gave their written
consent to participate in the study. This work was approved by the
Research Ethics Committee of the Andalusian Public Health
System (Comite´ de E´tica de la Investigacio´n del SSPA CEI-
Granada).
Determination of Cell Viability by Trypan Blue Dye
Exclusion Test and LIVE/DEADH Assay
To determine cell viability by using a dye exclusion test, we first
used Trypan blue methods. After cell isolation, subconfluent
cultures of TMJF were detached by using trypsin-EDTA for 8 min
at 37uC and 100 ml of the cell suspension were stained and mixed
with 0.4% trypan blue solution (Sigma-Aldrich ref. T8154) and
incubated for 5 minutes at room temperature. The percentage of
viable cells was quantified using a Neubauer chamber and a Nikon
Eclipse 90 i light microscope by counting a minimum of 200 cells
per cell passage. For each cell passage, a total of 6 determinations
were carried out and means and standard deviations were
calculated.
Then, we used a combined dye exclusion test (ethidium
homodimer-1) and a cytoplasmic metabolic analysis (Calcein
acetoxymethyl) to determine cell viability. With this purpose, we
used Live/DeadTM Viability/Cytotoxicity kit (Molecular Probes,
UK). Briefly, TMJF were seeded on chamber slides (Lab-Tek
Chamber Slides, Nunc, Roskilde, Denmark) in a cell density of
56103, cells were washed with phosphate-buffered saline (PBS) for
30 min, and samples were then incubated in 200 ml a Live/
DeadTM Viability/Cytotoxicity solution for 30 min. After staining,
samples were washed and observed using a Nikon Eclipse 90i
fluorescence microscope. For each cell passage, a total of 6
determinations were carried out and the mean and standard
deviation was calculated.
Determination of Cell Viability by Electron-probe X-ray
Microanalysis (EPXMA)
For EPXMA, TMJF cells were cultured on pretreated piolo-
form-covered gold grids in a cell density of 56103 following
previously described methods [12,13]. Afterwards, gold grids
containing TMJF were washed to remove extracellular medium
using ice-cold distilled water for 5 sec and immediately drained
and plunge-frozen in liquid nitrogen. After cryofixation, cells were
freeze-dried for 23 h using a 6-segment protocol from 2100uC to
25uC using a EMITECH K775X equipment. Subsequently,
samples were carbon-coated. Electron probe X-ray microanalysis
of the specimens was performed with a Philips XL30 scanning
electron microscope (SEM) equipped with an EDAX DX-4
microanalytical system and a solid-state backscattered electron
detector. Samples were examined with SEM with a combination
of secondary electron (SE) and backscattered electron (BSE)
imaging modes. For X-ray microanalysis, the analytical conditions
were: tilt angle 0u, take-off angle 61.34u and working distance
10 mm. The acceleration voltage was 10 kV. All spectra were
collected in the spot mode at 10,0006 (equivalent to 50 nm spot
diameter) for 200 sec live time, and the number of counts per
second recorded by the detector was around 500. All determina-
tions were performed on the central area of the cell nucleus. To
determine total intracellular ionic content, we used the peak-to-
local-background (P/B) ratio method [14] with reference to
standards composed of 20% dextran containing known amounts of
inorganic salts [15]. In this work, we analyzed the ionic content of
35 TMJF corresponding to each cell passage (P1 to P9) using 4
different individuals of each passage.
Global Gene Expression Analysis by Gene Expression
Microarray
Total RNA was isolated from two different samples corre-
sponding to TMJF cells at each cell passage (P1 to P9) by using
Qiagen RNeasy SystemTM (Qiagen, Mississauga, Ontario, Can-
ada). Total RNA was converted into cDNA using a reverse
transcriptase (Superscript II, Life Technologies, Inc., Carlsbad,
California, EEUU) and a T7-oligo(dT) primer. Then, biotinilated
cRNA was generated by using a T7 RNA polymerase and biotin-
11-uridine-59-triphosphate (Enzo Diagnostics, Farmingdale,
Nueva York, EEUU). Labeled cRNA were chemically fragmented
to facilitate the process of hybridization and hybridized to
Affymetrix Human Genome U133 plus 2.0 oligonucleotide arrays
for 6 hours at 45uC.
Statistical Analysis
For trypan blue and Live/DeadTM Viability/Cytotoxicity
methods, statistical differences between cell viability levels
corresponding to two consecutive cell passages (for instance, P1
vs. P2), were analyzed by using Wilcoxon non-parametric tests. To
compare the 9 cell passages globally (P1 to P9), we used Kendall W
tests. The same tests were used to compare intracellular ionic
contents of Na, K, Ca, Cl, Mg, P and S corresponding to 9 cell
passages. All tests were carried out double-tailed, and p values
below 0.01 were considered as statistically significant.
To determine the cell viability index for each cell passage, we
first normalized the cell viability levels obtained for each particular
method (trypan blue, Live/DeadTM Viability/Cytotoxicity and
EPXMA K/Na ratio) to z-scores (mean= 0 and standard
deviation = 1) using the formula: Z= (X-m)/s, where m is the
average cell viability obtained for each individual method, X is the
specific cell viability for a specific cell passage, and s is the
standard deviation for each particular method. Then, a global
average was calculated for each cell passage using the normalized
values obtained from the three methods separately.
For the analysis of expression values as determined by
microarray, we first selected three groups of genes and probe-
sets by using the information provided by Affymetrix. These
groups of genes were related to 1) cell viability, apoptosis and cell
death; 2) extracellular matrix components; and 3) PCNA and
MKI67 cell proliferation genes.
For the analysis of genes with significant correlation with the cell
viability index, we used the 3.09 b version of the Significance
Fibrochondrocytes Function and Viability
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Analysis of Microarrays (SAM) software of Stanford University,
using a d value that permitted a false discovery rate of 0 (i.e., no
genes are falsely named). A multiclass analysis of all cell viability,
apoptosis and cell death genes associated with the cell viability
index was performed. This program is available at http://www-
stat.stanford.edu/˜tibs/SAM/.
To determine the correlation between sequential cell passaging
and gene expression of the main ECM components, we used
Pearson (r) correlation tests. All genes with a r correlation
coefficient .0.700 were selected as positively correlated with cell
passaging, whereas genes with a r correlation coefficient ,20.700
were selected as negatively correlated with cell passaging.
To compare PCNA and MKI67 gene expression levels between
two consecutive cell passages (for instance, P1 vs. P2), we used
Wilcoxon non-parametric tests. To analyze the 9 cell passages
globally (P1 to P9), we used Kendall W tests. To determine a
correlation between the expression of PCNA and MKI67, we used
Kendal Tau correlation tests.
Results
Analysis of Cell Viability of 9 Consecutive Cell Passages of
TMJF
First, trypan blue exclusion tests demonstrated that the cell
viability of nine consecutive TMJF passages was very high, with
more than 93% of viable cells at each cell passage, and with a
maximum cell viability rate of 99.46% at P6 (Table 1). The
statistical analysis (Table 2) demonstrated the existence of global
significant differences among all 9 cell passages analyzed here
(p = 0.000 for the W test of Kendall). However, pair-wise
comparisons between two consecutive passages did not reveal
any significant differences in cell survival among consecutive
passages, although a non-significant trend to decrease was found
until P4, with a subsequent increase to P6 and a final decrease
until P9, with the lowest viability corresponding to P9.
In the second place, the results obtained with Live/DeadTM
Viability/Cytotoxicity assays showed that the lowest rate of
viability corresponded to P1 and P2 (Table 1). From there, an
increasing cell viability trend was found from P3 to P7, with a final
decrease until P9. No statistical differences were found for any of
the statistical comparisons carried out (Table 2).
In addition, the analysis of cell viability as determined by
electron-probe X-ray microanalysis of 9 consecutive TMJF
subcultures showed that the K/Na ratio was high in all cell
passages, ranging from 2.08 at P9 to 7.02 at P6, showing
increasing levels from P2 to P6 and a trend to decrease from P6 to
P9 (Table 1 and Figure 1). When specific intracellular elements
were analyzed (Ca, Cl, K, Mg, Na, P and S), we found statistically
significant differences among all 9 cells passages globally analyzed
(p = 0.000 for the W test of Kendall), suggesting that the
intracellular concentration of these elements significantly varied
among all 9 cell passages (Table 2). The analysis of intracellular K
concentrations showed some significant variations, being especially
remarkable a decrease found from P1 to P2, an increase from P3
to P4 and a final decrease from P8 to P9 (Figure 1). The
intracellular Na concentrations showed a significant increase at P2
and at the final passages P8 and P9. When chlorine concentrations
were microanalyzed, we found that the highest ionic levels were
found at P6, with a significant increase from P5 to P6 and a
significant decrease from P6 to P7 (Figure 1). Interestingly, the
concentration of phosphorous significantly varied at some cell
passages. Among others, a significant decrease was detected from
P1 to P2 and from P8 to P9. Similarly, the concentration of Mg
significantly decreased at P9. Regarding the concentrations of S,
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this element reached the highest concentrations at P6, with a
significant increase from P5 to P6 and a significant decrease from
P6 to P7. The concentrations of calcium significantly decreased
from P4 to P5.
Based on the results of trypan blue exclusion tests, Live/
DeadTM Viability/Cytotoxicity Assay and the intracellular K/Na
concentrations as determined by electron-probe X-ray microanal-
ysis assays, we calculated the cell viability index for each cell
passage. As shown in Figure 2, the highest cell viability index
corresponded to the sixth cell passage (P6), followed by P5 and P7,
with the lowest values corresponding to P9, followed by P2.
Finally, the SAM analysis of microarray-determined gene
expression values (Figure 3) demonstrated that 6 probe sets
corresponding to 5 genes were inversely associated to the cell
viability index, including 2 genes with a role in apoptosis induction
(TRAF5, GO:0006915 apoptotic process; and PHLDA1,
GO:0006917 induction of apoptosis and GO:0006915 apoptotic
process) and 3 genes with a role in apoptosis inhibition (SON,
HTT and FAIM2, GO:0006916 anti-apoptosis for the 3 genes).
The highest expression of all these 5 genes significantly correlated
with the lowest cell viability index. None of the genes in the array
was positively correlated with the cell viability index.
Expression of ECM Components Along 9 Consecutive Cell
Passages of TMJF
The analysis of 49 fibrillar components of the fibrocartilage
ECM showed a significant diminution of the expression of several
genes along the nine consecutive cell passages, including two genes
encoding for collagen type I and procollagen (COL1A1, COL1A2,
PLOD1 and PLOD2) representing 32% of all fibrillar genes. The
rest of the fibrillar components genes (68%) did not show any
relevant significance (Table 3).
Once we analyzed the fibrillar components of the fibrocartilage
ECM, we performed the analysis of non-fibrillar components of
the ECM by quantifying the expression of the main glucosami-
noglycans (GAGs), proteoglycans (PGs), multiadhesive gluproteins
(MGPs) and other ECM genes (Table 3). As the result of this, we
found that 6 GAGs genes (17% of genes) notably decreased after
continuous cell passaging, including some genes related to
chondroitin-sulfate, hyaluronic acid and heparan-sulfate synthesis
such as CHST12, CSGALNACT1, HAS1 and HS6ST2. How-
ever, the gene expression of two genes (5% of all genes) with a role
in heparan-sulfate metabolism were increased (correlation coeffi-
cient r.0.7) and the rest of the genes (78% of all genes) did not
differ. The study of 13 markers related to PGs synthesis
demonstrated that the expression of 3 genes, aggrecan, biglycan
and decorin (24% of all genes) significantly decreased after nine
consecutive subcultures, although 10 genes (76% of all genes) did
not show any variation. Regarding the study of 19 MGPs genes, 3
of them (16%) showed a decreasing tendency, including nidogen,
osteonectin and tenascin (NID2, SPARC and TNC), whilst two
genes (10%) encoding for laminin (LAMA4 and LAMB1) showed
the inverse tendency along cell passaging. Finally, the analysis of
other genes with a role in cartilage generation and metabolism
showed a significant decrease of 6 genes (43% of all genes)
including CHODL, CILP, COMP, CRTA1 and FMOD.
Analysis of Cell Proliferation of 9 Consecutive Cell
Passages of TMJF
The mRNA expression of PCNA and MKI67 as determined by
microarray analysis showed that the expression of both genes was
high at most cell passages, with a reduction at P9 (Figure 4). The
statistical analysis revealed that differences between passages were
not significant, and a positive correlation was found between the
expression levels of both PCNA and MKI67 (p = 0.0250 and
r = 0.3907 for the correlation test).
Discussion
A therapeutic advance in the treatment of TMJ pathological
conditions could be the generation of biological substitutes of
damaged discs generated by tissue engineering. Different models
of engineered TMJ disc have been developed by using animal cells
and different biomaterials and signaling [16]. In most of these
studies, the key importance of an accurate cell viability determi-
nation has been established, since only viable cells should be used
for TMJ disc tissue engineering [7,9,17]. Most current research
works focused on TMJ disc regeneration have been developed by
using animal cell sources including goat, calf, pig and rabbit [18].
Studies developed by Athanasiu [16] on goat costal chondrocytes
demonstrated that the proliferative ability of the cells decreased
Table 2. Statistical p values for the comparisons of the cell viability levels as determined by trypan blue dye exclusion test, and
LIVE/DEADTM Cell viability assay and the intracellular ionic concentration of calcium, chlorine, potassium, magnesium, sodium,
phosphorous and sulfur in 9 consecutive cell passages of TMJF.
P1–P2 P2–P3 P3–P4 P4–P5 P5–P6 P6–P7 P7–P8 P8–P9 All (Kendall W)
TRYPA´N BLUE
Exclusion test
0.1128 0.0264 0.9158 0.0264 0.0264 0.0264 0.1128 0.0264 0.0001*
LIVE/DEADTM Cell
Viability Assay
0.7532 0.1730 0.9165 0.2489 0.7150 1.0000 0.0747 0.1730 0.3594
Ca 0.9932 0.0401 0.9501 0.0028* 0.9262 0.7221 0.8733 0.0180 0.0001*
Cl 0.3926 0.0000* 0.0312 0.2162 0.0005* 0.0001* 0.0051* 0.6822 0.0000*
K 0.0001* 0.3339 0.0002* 0.1635 0.0406 0.0000* 0.0000* 0.0000* 0.0000*
Mg 0.1877 0.4220 0.0003* 0.0106 0.3130 0.0001* 0.0000* 0.0026* 0.0000*
Na 0.0004* 0.0000* 0.0114 0.0092* 0.8508 0.0360 0.0000* 0.0018* 0.0000*
P 0.0013* 0.1157 0.0003* 0.0000* 0.0383 0.0000* 0.0000* 0.0007* 0.0000*
S 0.0001* 0.0294 0.0007* 0.0029* 0.0000* 0.0000* 0.0004* 0.0740 0.0000*
Pairwise comparisons between two consecutive cell passages were performed by using the Wilcoxon non-parametric test. The global significant differences among the
9 cell passages were analyzed by the W test of Kendall. Statistically significant p values are shown with asterisks (*).
doi:10.1371/journal.pone.0051961.t002
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Figure 2. Cell viability index of 9 consecutive cell passages (P1 to P9) of TMJF obtained by normalization of trypan blue dye test,
LIVE/DEADTM Cell viability assay and EPXMA (K/Na ratio) values.
doi:10.1371/journal.pone.0051961.g002
Figure 1. Intracellular ionic concentrations of potassium, sodium, chlorine and K/Na ratio of 9 consecutive cell passages of TMJF
cells. Statistically significant differences between two consecutive cell passages are labeled with asterisks. All values are expressed as millimoles of
each element per kilogram of cell dry weight and are shown as mean 6 standard deviation.
doi:10.1371/journal.pone.0051961.g001
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after passage 5. In the present study, we have demonstrated that
human TMJ cells were highly proliferative at most cell passages,
with the lowest values found at P9. This could be possibly
associated to a senescence process. It is important to highlight that
most previous works have been performed in 5 or less cell
passages.
In terms of cell viability, the classical idea that early passage cells
are the most feasible for tissue engineering should be deeply
considered, because it has been previously demonstrated that the
earliest cell passages are frequently under adaptative conditions to
ex vivo environments [10,12] and they do not display the most
accurate conditions to be used in tissue engineering protocols. In
this sense, all cell sources should be previously characterized and
deeply studied using a combination of highly sensitive techniques
to select and determine the most accurate cell passage for
regeneration protocols. In this milieu, we recently described an
ACVL method to evaluate cell viability of human cells high
accuracy [10]. In the present work, we used a combined approach
based on the use of 3 different methods to determine a cell viability
index at different levels: cell membrane integrity, cytoplasmic
metabolism and intracellular ionic content.
Thus, our results revealed that the most viable cell passage of
cultured TMJF could be P6, although P5 and P7 also showed good
cell viability levels. Interestingly, the combination of classical
protocols as trypan blue assays and precise techniques such as
calcein/AM and ethidium homodimer-1 and electron-probe X-
ray microanalysis, showed a good correlation between classical
and novel assays to determine the cell behaviour of TMJF cells
along nine subcultures. First, the trypan blue assay, a classical
method that evaluates the cell membrane integrity evidenced high
cell viability levels in all cell passages analyzed here, with the
maximum cell viability at P6 which is in agreement with previous
results obtained using WHJSC [10]. In the second place, we
analyzed the enzymatic esterase cytoplasmatic activity and the
membrane integrity by using calcein/AM and ethidium homodi-
mer-1 assays. The results demonstrated that the most viable
passage was P7 followed by P6 and P5. In contrast with trypan
blue assays, this sensitive method showed that cell viability was
very variable among the nine cell passages. In fact, P1 and P2 in
junction with P9 were the less viable cell passages that were not
efficiently detected by trypan blue assay. This may suggest that
early stages of cell death in which the cell membrane has been not
damaged could not be efficiently detected by trypan blue. For this
reason, we hypothesize that the utilization of classical methods
(trypan blue) should be always accompanied by more sensitive
assays such as electron-probe X-ray microanalysis which allows us
to determine qualitative and quantitative intracellular concentra-
tions of key ions involved in cell viability. As we previously
described, this method is highly sensitive for determination of the
mechanisms of cell death that may occur after sequential cell
passaging [12]. The link between intracellular levels of potassium,
sodium, chlorine, calcium, sulfur, magnesium, phosphorous and
cellular physiology has been deeply studied and it is clear that a
close relationship exists between them. However, the intracellular
ionic contents of TMJF and their relation with cell functions have
not been previously described. In the first place, our results showed
Figure 3. Analysis of genes significantly associated to the cell viability index as determined by the Significance Analysis of
Microarray (SAM) software. All significant genes are represented in green color on the plot.
doi:10.1371/journal.pone.0051961.g003
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that the highest cell viability levels corresponded to P6 as
determined by K/Na ratio followed by P8 and P5. Several studies
[19,20] previously confirmed the high accuracy of K/Na ratio as
cell viability indicator with K, Na and Cl being the most sensitive
and reliable marks. Strikingly, these results correlated very well
with the classical and metabolic assays, thus confirming our results.
Generally, low concentrations of intracellular potassium and high
Na contents are associated to apoptosis, which can be detected in
early pre-apoptotic stages by a decrease of Cl concentrations
[10,12]. In this regard, our results showed that an apoptotic
process could be triggered from P1 to P2 and from P6 to P7,
suggesting that P7 could not be viable. Moreover, high concen-
trations of sulfur and phosphorous and moderate concentrations of
magnesium and calcium were also found at P6. From a
microanalytical point of view, phosphorus is an element that is
associated with cell mass and organic constituents, nucleic acids
contents and the level of cellular phosphorylation, and cells
characterized by a severe structural damage show a decrease in
intracellular concentrations of phosphorus [21]. Therefore, the
high values found at P6 would confirm the vital status of these
cells, whereas the decrease at P7 could be related to a possible
structural damage of these cells. In addition, magnesium has been
associated with cellular ATP levels and a concentration decrease of
magnesium is correlated with a decrease in cellular ATP
concentration [22], phosphorylation, and DNA replication. The
results obtained in this work suggest that cells of the TMJ articular
disc of human adults would experience a decrease in ATP content
in some cell passages, especially at P7. Similarly, the concentration
of sulfur was high at P6. These results must be correlated with the
participation of sulfur in the metabolism of sulfated proteins,
proteoglycans and glycoproteins that are very important in these
cells [23]. Finally, the lowest calcium values at P8 and the highest
levels at P3 might be explained by cell viability alteration at these
passages.
Once we determined cell viability at different levels, we
obtained an average cell viability index that provides comprehen-
sive information about the vital status of these cells. In summary,
our combined cell viability analysis approach suggests that the
most adequate cell passage for use in cell therapy could be P6,
implying that these cells should preferably be used at this passage.
The cell viability index results found that the most viable passages
were P6 and P5. In these passages we found a perfect match with
high levels of proliferation, low cell damage of the cell membrane
as determined by trypan blue, and high metabolic activity along
with an adequate equilibrium of sodium, magnesium, phospho-
rous, potassium, calcium, sulfur and chlorine levels. In contrast, P2
and P9 demonstrated to be the cell passages with compromised
cell proliferation, ATP levels, cell volume, synthesis of sulfated
proteins and evident alteration of the K/Na pump. This combined
cell viability approach is likely to be much more accurate than the
use of a single method or technique to evaluate cell viability, and
gives valuable information on the metabolic and structural cell
status. In fact, several studies previously carried out on articular
cartilage found that the use of cultured human hyaline chondro-
cytes could not be clinically useful [7,24,25] Perhaps, some of these
studies did not use the most viable cell passages and cell viability
was determined by using single, low sensitive techniques.
In this work we were able to identify some of the genes that
could be responsible for the differential cell viability levels found
among 9 successive TMJF cell passages. Thus, our significance
analysis of microarray data (SAM) showed that the expression of 5
genes linked to different pro or anti-apoptotic activities was
significantly associated to average cell viability. On one hand, two
apoptotic genes -TRAF5 and PHLDA1- [26] were inversely
correlated with the average cell viability, and the expression of
both genes was higher in cell passages with the lowest cell viability.
Although functional genetic studies should be carried out to
confirm this statement, these results may suggest that these genes
could play a role on inducing apoptotic cell death in the passages
with lower cell viability, and they could be responsible of the
differential cell viability levels found among the different cell
passages analyzed in this work. On the other hand, three
Figure 4. Analysis of cell proliferation of 9 TMJF cell passages by microarray. Average expression of the proliferation-related genes PCNA
(in blue) and MKI67 (in red) are shown for each cell passage.
doi:10.1371/journal.pone.0051961.g004
Fibrochondrocytes Function and Viability
PLOS ONE | www.plosone.org 12 December 2012 | Volume 7 | Issue 12 | e51961
apoptosis-inhibitor genes (SON, HTT and FAIM2) were inversely
correlated with the average cell viability. In the first place, SON
has been described as a gene involved in protecting cells from
apoptosis. SON regulates the mitotic machinery, such as
centrosome components and genes critical for microtubule
dynamics, as well as the DNA repair machinery. Recent findings
also predicted SON to be a master regulator of multiple cellular
processes that depend on microtubules, including cell death [27].
In the second place, HTT may play a role in microtubule-
mediated transport or vesicle function. Moreover, this gene could
also be involved in signalling, transporting materials, binding
proteins and other structures, and protecting against programmed
cell death [28]. Similarly FAIM2 (Fas apoptotic inhibitory
molecule 2) is able to protect cells from apoptosis [29] probably,
when the average cell viability was high, these three apoptosis
inhibitor genes were up-regulated in compensation and control of
pro-apoptotic genes. This compensatory mechanism could create
a life-death equilibrium along the 9 cell passages. However, the
activation of pre and anti-apoptotic genes could also be explained
by the presence of a mixed population of viable and non-viable
cells.
Once we determined cell viability and cell proliferation on 9
sequential TMJF cell passages, we analyzed the function of these
cells as putative fibrocartilage-forming cells. In this regard, it is
important to determine the capability of these cells to synthesize
and remodel the fibrocartilage ECM, including ECM fibrillar and
non fibrillar components. At this point, we should reconsider that
selection of an adequate cell passage of TMJF cells could be a key
step to ensure the success of translational clinical approaches, not
only from the standpoint of cell viability, but also from the
functional point of view. However, numerous authors have
reported that TMJ cells are prone to change their phenotype
and often stop the synthesis of cartilage-specific molecules during
culture and after sequential cell passaging [9,16,30]. For these
reasons, the genetic changes that could take place along 9
consecutive cell passages of human TMJ disc cells still needs to be
clarified. In the first place, our analysis revealed that expression of
15 ECM fibrillar components significantly decreased along all nine
cell passages, although 68% of the genes did not significantly vary.
It is noteworthy that some genes encoding for collagen I tended to
decrease with subculturing as previously demonstrated by other
authors [30]. Collagen I forms a major structural framework of the
fibrocartilage ECM [31], and it is essential to maintain the
biomechanical properties of this cartilage. For that reason, cells
intended for future clinical use should express physiological
amounts of these genes. Interestingly, although the highest coll I
expression corresponded to the first 3 cell passages, the levels of
coll I expression were high at all 9 cell passages analyzed here
(.2.300 f.u.), suggesting that all passages could be able to express
adequate coll I amounts. Another relevant ECM fibrillar
component of the TMJ disc is coll II. Strikingly, the expression
of this protein was low at all passages, which is in agreement with
previous reports [31], and it did not vary along subculturing.
Other less abundant collagen fibers such as coll III, IV, V, VI, IX,
XII, XV and XVI also tended to decrease with sequential
passaging. In general, these collagens form a 3-D structure that
associates with coll I and II to constitute the main scaffold of the
cartilage TMJ. Taking together, these results imply that most
fibrillar ECM components did not vary with sequential culturing
and, in the cases that tended to decrease, the expression levels are
relatively high at most subcultures.
In the second place, the analysis of non-fibrillar ECM
components confirmed that the majority of genes did not decrease
along consecutive cell passaging, although some specific genes did
significantly vary upon subculturing. Non-fibrillar components of
the ECM play an important role in cartilage homeostasis, cell
adhesion and hydrostatic balance. One of the most important non-
fibrillar ECM components are glucosaminoglycans and muco-
polysaccharides that tend to associate to proteins to form
proteoglycans, which are able to attract water molecules via
osmosis to keep the ECM hydrated, as well as growth factors [32].
In this regard, it is important to note that several relevant GAGs
and PGs maintained their expression during sequential culturing
including, versican, lumican, dermatan sulfate, etc. However, our
results reveal that some genes could diminish their expression
upon subculturing, including biglycan, decorin aggrecan and some
genes encoding for chondroitin-sulfate, hyaluronic acid and
heparan sulfate. This finding suggests that TMJF cells could not
be able to generate an efficient fibrocartilage ECM at advanced
cell passages. Chondroitin-sulfate may be the predominant
proteoglycan present in cartilage. Interestingly, the highest
intracellular sulfur concentrations correlated with the highest
expression of chondroitin-sulfate genes, with the most functional
levels found at P4 and P5. Hyaluronan synthase 1 (HAS1) plays a
role in of hyaluronan/hyaluronic acid (HA) synthesis and may be
involved in prevention of cartilage destruction by the continuous
production of HA [33,34]. However, the tendency to decrease that
we found here reveals that these cultured cells should be used at
the earliest cell passages.
On the other hand, biglycan, aggrecan and decorin are crucial
components of the ECM. These proteins are involved in collagen
fiber assembly and play an important role in the organization of
the fibrillar ECM. Although the decreasing trend of these three
proteins suggests that they should be used at the first cell passages,
the gene expression levels of these elements were high at P5 as
determined by microarray. Regarding other ECM proteins of
interest, including glycoproteins our results showed that some
cartilage-related genes decreased with culturing including chon-
drolectin, cartilage intermediate layer protein and cartilage
oligomeric matrix protein, whereas two laminin genes tended to
increase. Notwithstanding the role of these ECM components is
less known, these results point out the need to use early cell
passages in regenerative protocols. All our findings related to ECM
components expression could suggest that TMJF cells could be
functionally adequate until at least P5. The behavior from P5 to
P9 could be associated to response mechanism to the de-
differentiation effects caused by ex vivo adaptative conditions. In
this context, is well known that the lack of cell-cell interaction and
cell matrix interactions could play a major role in altering the gene
expression of cultured chondrocytes [9] and the re-differentiation
process is an attractive strategy for TMJF cells.
In summary, all these results allow us to suggest that
determination of cell viability and functionality of human TMJF
cell kept in culture using highly-sensitive methods must be one of
the key parameters that should be determined during the quality
control of TMJF for clinical cell transplantation, and we propose
that all cells to be used for clinical purposes be previously analyzed
using the highly-sensitive methods used in this work. In general,
our data imply that the highest cell viability levels correspond to
TMJF passages 6 and 5 and the most functional passage is the
passage 5. We therefore suggest that cell passages P5 and P6
should be preferentially used in cell therapy and tissue engineering
protocols using this cell type.
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